Clinical Trial
VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
ClinicalTrials.gov10/3/2025Β·10/03/25πΊπΈ USA
Summary
The VOICE study is an early feasibility trial of Neuralink's N1 implant, placed by the R1 surgical robot, to restore the ability to communicate in adults with severe speech impairment. Enrollment is limited to 6 participants with conditions including tetraplegia, cervical spinal cord injury, ALS and stroke. The registry lists the study as recruiting, with a start in October 2025 and primary completion expected in October 2028.
Why it matters
It is Neuralink's registered speech-restoration trial, extending its implant beyond cursor control. At six participants it is a small safety and feasibility study, so it says little yet about efficacy.
#Early Feasibility#Neural Interfaces#Neural Recording#Neuroprosthetics#ALS#Spinal Cord Injury#Stroke Rehabilitation#USA
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items β updated daily.
Start free trialAlready a member? Sign in